Richard Douglas
Chairman at ALDEYRA THERAPEUTICS, INC.
Net worth: 1 M $ as of 2024-04-29
Profile
Dr. Richard H.
Douglas is an Independent Chairman at MaxCyte, Inc., a Chairman at Aldeyra Therapeutics, Inc. and an Independent Director at Novavax, Inc. He is on the Board of Directors at Novavax, Inc., Intercell USA, Inc., Helio Vision, Inc. and Labyrinth Choir, Inc. Dr. Douglas was previously employed as a Senior Vice President-Corporate Development by Genzyme Corp.
and a Director-New Product Development by Integrated Genetics, Inc. He received his undergraduate degree from the University of Michigan and a doctorate degree from the University of California, Berkeley.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
2024-04-08 | 125,000 ( 0.21% ) | 492 500 $ | 2024-04-29 | |
MAXCYTE, INC.
0.10% | 2023-06-21 | 100,000 ( 0.10% ) | 369 000 $ | 2024-04-29 |
NOVAVAX, INC.
0.03% | 2023-06-11 | 37,250 ( 0.03% ) | 147 138 $ | 2024-04-29 |
Richard Douglas active positions
Companies | Position | Start |
---|---|---|
IOMAI CORPORATION | Director/Board Member | 2001-12-31 |
NOVAVAX, INC. | Director/Board Member | 2010-08-05 |
ALDEYRA THERAPEUTICS, INC. | Chairman | - |
MAXCYTE, INC. | Chairman | 2021-11-02 |
Labyrinth Choir, Inc. | Director/Board Member | - |
Helio Vision, Inc.
Helio Vision, Inc. Pharmaceuticals: MajorHealth Technology Helio Vision, Inc. operates as a biotechnology company. It develops a therapy for fibroproliferative disorders that lead to abnormal scarring and blindness after retina surgery. The company was founded by Josef H. von Rickenbach, Dean Eliott and Tomasz P. Stryjewski in 2016 and is headquartered in Waltham, MA. | Director/Board Member | - |
Former positions of Richard Douglas
Companies | Position | End |
---|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 2010-12-31 |
Integrated Genetics, Inc.
Integrated Genetics, Inc. Pharmaceuticals: MajorHealth Technology Part of Laboratory Corp. of America Holdings, Integrated Genetics, Inc. is a pharmaceutical preparations company. The private company is based in Framingham, MA. The company was founded by Robert J. Carpenter. | Corporate Officer/Principal | 1988-12-31 |
Training of Richard Douglas
University of California, Berkeley | Doctorate Degree |
University of Michigan | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 3 |
---|---|
NOVAVAX, INC. | Health Technology |
MAXCYTE, INC. | Health Technology |
ALDEYRA THERAPEUTICS, INC. | Health Technology |
Private companies | 5 |
---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Intercell USA, Inc.
Intercell USA, Inc. BiotechnologyHealth Technology Intercell USA, Inc. discovers and develops vaccines and immune system stimulants. The vaccine patch enhances the efficacy of existing vaccines, enables new vaccines that are viable only through transcutaneous administration and expand the global vaccine market. The company was founded by Gregory M. Glenn and Dean P. Lewis in September 1997 and is headquartered in Gaithersburg, MD. | Health Technology |
Integrated Genetics, Inc.
Integrated Genetics, Inc. Pharmaceuticals: MajorHealth Technology Part of Laboratory Corp. of America Holdings, Integrated Genetics, Inc. is a pharmaceutical preparations company. The private company is based in Framingham, MA. The company was founded by Robert J. Carpenter. | Health Technology |
Helio Vision, Inc.
Helio Vision, Inc. Pharmaceuticals: MajorHealth Technology Helio Vision, Inc. operates as a biotechnology company. It develops a therapy for fibroproliferative disorders that lead to abnormal scarring and blindness after retina surgery. The company was founded by Josef H. von Rickenbach, Dean Eliott and Tomasz P. Stryjewski in 2016 and is headquartered in Waltham, MA. | Health Technology |
Labyrinth Choir, Inc. |
- Stock Market
- Insiders
- Richard Douglas